Target intelligence / Profile preview

Ribosomal protein L9 pseudogene 33 (RPL9P33)

Target
RPL9P33
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L9 pseudogene 33 (RPL9P33) is a human pseudogene that shares sequence similarity with the functional ribosomal protein L9 gene (RPL9)[4][3]. Pseudogenes such as RPL9P33 are segments of DNA that resemble known genes but are nonfunctional, usually due to mutations or lack of regulatory elements required for gene expression and protein production[5]. RPL9P33 does not code for a protein product, is not involved in ribosomal assembly, protein synthesis, or any known biological pathway, and has no direct links to disease or pharmacological targeting. Information available for RPL9P33 confirms its classification as a processed pseudogene, with no therapeutic relevance or targeting potential[4]. RPL9P33 should not be confused with RPL9 (Ribosomal protein L9), which encodes a component of the 60S large ribosomal subunit, participates in protein biosynthesis, and can be involved in disease processes such as Diamond-Blackfan anemia[7]. However, the pseudogene RPL9P33 itself has no such functions or clinical associations[4][3].

Other names
RPL9P33RPL9_13_1663RPL9P33[4]
02

Mechanism of action

None

03

Biological functions

None (no known biological function as it is a pseudogene)
04

Disease associations

None (not implicated directly in disease; parent gene is sometimes implicated, but pseudogene is not)

Beyond the preview

Go deeper on Ribosomal protein L9 pseudogene 33 (RPL9P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L9 pseudogene 33 (RPL9P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call